A Drug To Reduce The Side Effects Of A Multiple Sclerosis Treatment
Links shared publicly online about this topic.
- 303total visits
A Drug To Reduce The Side Effects Of A Multiple Sclerosis Treatment
View full resource at medicalnewstoday.com
Tags: Multiple Sclerosis, Eye, Lung, Drug
Most Recently Shared on May 10, 2011 at 2:07 pm By:
A Drug To Reduce The Side Effects Of A Multiple Sclerosis Treatment: The drug FTY720 is approved for the treatme... http://bit.ly/mRRH3T
Could MS Drug be an Effective Treatment for Spinal Cord Injuries? - ABC News
abcnews.go.com — “A drug found to slow some of the physical problems and reduce the number of flareups of multiple sclerosis (MS) could also show promise for treating spinal cord injuries, according to a new Japanese study.” View full resource at abcnews.go.com
Most Recently Shared on March 13, 2012 at 8:45 am By:
HealthIT Policy Health IT and Health News
MS Drug Effective for Spinal Cord Injuries?: A drug found to slow some of the physical problems and reduce the n... http://t.co/oV4Zc56D
A Drug To Reduce The Side Effects Of A Multiple Sclerosis Treatment
medicalnewstoday.com — “The drug FTY720 is approved for the treatment of multiple sclerosis. Although highly effective it can have serious side effects, including reduced lung function and fluid accumulation in the eye.” View full resource at medicalnewstoday.com
Most Recently Shared on May 10, 2011 at 9:05 am By:
A Drug To Reduce The Side Effects Of A Multiple Sclerosis Treatment http://mnt.to/3VCc #multiplesclerosis
Reducing the side effects of a multiple sclerosis drug
sciencedaily.com — “The drug FTY720 is approved for the treatment of multiple sclerosis. Although highly effective it can have serious side effects. Understanding the molecular mechanisms by which the drug affects its target could lead to the development of a drug with the same therapeutic efficacy but reduced side effects. In this context, researchers have now detailed the molecular mechanism by which FTY270 causes adverse effects in the lungs of mice.” View full resource at sciencedaily.com
Most Recently Shared on May 10, 2011 at 2:04 am By:
Reducing the side effects of a multiple sclerosis drug: The drug FTY720 is approved for the treatment of multipl... http://bit.ly/lYeZcM
Reducing the side effects of a multiple sclerosis drug
eurekalert.org — “The drug FTY720 is approved for the treatment of multiple sclerosis. Although highly effective it can have serious side effects. Understanding the molecular mechanisms by which the drug affects its target could lead to the development of a drug with the same therapeutic efficacy but reduced side effects. In this context, researchers have now detailed the molecular mechanism by which FTY270 causes adverse effects in the lungs of mice.” View full resource at eurekalert.org
Most Recently Shared on May 9, 2011 at 8:04 pm By:
Reducing the side effects of a multiple sclerosis drug: The drug FTY720 is approved for the treatment of multipl... http://bit.ly/m6Yz79
Reducing the side effects of a multiple sclerosis drug
medicalxpress.com — “The drug FTY720 is approved for the treatment of multiple sclerosis. Although highly effective it can have serious side effects, including reduced lung function and fluid accumulation in the eye.” View full resource at medicalxpress.com
Most Recently Shared on May 9, 2011 at 4:34 pm By:
PhysOrg Health News Health News
Reducing the side effects of a multiple sclerosis drug http://tw.medicalxpress.com/224163234
Elan Gains Most in 3 Months After Tysabri Comments - Bloomberg
bloomberg.com — “Elan Corp. rose the most in three months after a Berenberg Bank analyst said the share price doesn--™t recognize the value of Tysabri and the potential for the Irish drugmaker--™s Alzheimer--™s treatment, bapineuzumab.” View full resource at bloomberg.com
Most Recently Shared on April 7, 2011 at 1:59 pm By:
ScienceintheTriangle Science Enthusiast
Test to assess risk of deadly side effect boosts Tysabri, MS drug Biogen Idec makes in RTP. (Bloomberg) http://bloom.bg/hpHBn9 #SITT
Merck Receives Complete Response Letter From FDA on Cladribine Tablets New Drug Application
drugs.com — “Cladribine (Tablets) is a new drug formulation for the treatment of multiple sclerosis. Cladribine Tablets information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on March 9, 2011 at 10:17 pm By:
Drugs and Devices OW OW Health
Merck Receives Complete Response Letter From FDA on Cladribine Tablets New Drug Application: DARMSTADT, Ge... http://bit.ly/fzXQnq #drug
Chemotherapy | Chemo Drugs, Types and Side Effects | Cancer Treatment
knowcancer.com — “Chemotherapy is the use of chemical agents to kill cells. In conversational usage, the term chemotherapy refers to the chemical treatment of cancer. But chemical agents are also used to treat multiple sclerosis (MS), various autoimmune diseases, and” View full resource at knowcancer.com
Most Recently Shared on February 4, 2011 at 7:00 pm By:
Use your noggin and avoid chemo brain! If you or someone you love is dealing w/ #cancer read this article on chemo! http://ow.ly/3K43l
Early Initiation of Treatment with Copaxone Provides Greater Effects in Delaying Conversion to Clinically Definite MS - Drugs.com MedNews
drugs.com — “Early Initiation of Treatment with Copaxone Reduced the Risk of Developing MS by 41 Percent Copaxone Delayed Time to Conversion to Clinically Definite MS by Alm” View full resource at drugs.com
Most Recently Shared on October 20, 2010 at 3:12 pm By:
Drugs and Devices OW OW Health
Early Initiation of Treatment with Copaxone Provides Greater Effects in Delaying Conversion to Clinically Def... http://bit.ly/cAGrWu #drug
Novartis Gains FDA Approval For Gilenya, A Novel First-Line Multiple Sclerosis Treatment Shown To Significantly Reduce Relapses And Delay Disability Progression
drugs.com — “Gilenya (fingolimod) is used to treat relapsing forms of multiple sclerosis. Includes Gilenya side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 22, 2010 at 11:41 pm By:
FDA Approves Gilenya, A Novel First-Line Multiple Sclerosis Treatment - http://bit.ly/ddfXwp
Novartis Gains FDA Approval For Gilenya, A Novel First-Line Multiple Sclerosis Treatment Shown To Significantly Reduce Relapses And Delay Disability Progression
drugs.com — “Gilenya (fingolimod) is used to treat relapsing forms of multiple sclerosis. Includes Gilenya side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 22, 2010 at 11:17 pm By:
Drugs and Devices OW OW Health
Novartis Gains FDA Approval For Gilenya, A Novel First-Line Multiple Sclerosis Treatment Shown To Significant... http://bit.ly/dp1Zza #drug
Little pill means big news in the treatment of MS
eurekalert.org — “A new drug for multiple sclerosis promises to change the lives of the 100,000 people in the UK who have the condition, say researchers at Queen Mary, University of London. A major trial of the oral drug Cladribine -- results of which are published in the NEJM on Jan. 20, 2010 -- has shown that it significantly reduces relapse and deterioration of the disease, and goes a long way to eliminating the unpleasant side effects associated with existing therapies.” View full resource at eurekalert.org
Most Recently Shared on January 21, 2010 at 10:33 am By:
Stephen Roberts, MD Doctor and Physician
Little pill big news 4 #MS - Cladribine 8x/yr => 55% drop relapse & 30% less progression #MultipleSclerosis http://bit.ly/7JwIMw
Strategies To Counteract Side Effects Of New MS Therapies
sciencedaily.com — “The drawback of new immunotherapies in multiple sclerosis (MS) include severe infections that can be fatal. For example, treatment with natalizumab, which reduces the immune surveillance of the brain, can lead to the development of progressive multifocal leukoencephalopathy (PML), a typically fatal form of viral encephalitis. Researchers recently employed plasmapheresis to eliminate the active pharmaceutical agent and thus clear the virus from the brain.” View full resource at sciencedaily.com
Most Recently Shared on September 14, 2009 at 5:44 pm By:
Strategies To Counteract Side Effects Of New MS Therapies http://ow.ly/15OYYH
Advertisement
